2016
DOI: 10.3892/etm.2016.3808
|View full text |Cite|
|
Sign up to set email alerts
|

Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension

Abstract: Abstract. The aim of the present study was to increase the intestinal transport of octreotide (OCT) by targeting the first-pass impact to identify a potential method for decreasing portal vein pressure (PVP) using oral OCT. Thus, the bioavailability of intestinally absorbed OCT was evaluated in normal rats and rats with portal hypertension (PH) that had been administered P-glycoprotein/multidrug resistance-associated protein 2/cytochrome P450 3A4 (P-gp/MRP2/CYP3A4) inhibitors. The mRNA and protein expression l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…The intestinal absorption of drugs was affected by numerous factors, such as transporters, and intestinal microflora [37]. However, the scope of this study sought to focus on the permeability features of CAPB and CAPC, along with the major transporters and metabolic enzymes in intestinal epithelium including P-gp, MRP2 and CYP3A4 [5,13]. While previous studies have already evaluated the pharmacokinetics, distribution, intestinal metabolism, and excretion of CAPB and CAPC [31,32,33,34], the absorption characteristics of CAPB and CAPC in the intestinal tract were largely unknown.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The intestinal absorption of drugs was affected by numerous factors, such as transporters, and intestinal microflora [37]. However, the scope of this study sought to focus on the permeability features of CAPB and CAPC, along with the major transporters and metabolic enzymes in intestinal epithelium including P-gp, MRP2 and CYP3A4 [5,13]. While previous studies have already evaluated the pharmacokinetics, distribution, intestinal metabolism, and excretion of CAPB and CAPC [31,32,33,34], the absorption characteristics of CAPB and CAPC in the intestinal tract were largely unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Aside from ABC transporters, drug metabolism enzymes are also critical factors in determining the bioavailability of drugs, among which the cytochrome P450 enzyme (CYP450) plays a major role [13]. The CYP3A4 subset of CYP450 accounts for 30% of the total CYP450 enzyme system [14,15] and is responsible for the bio-transformation of several drugs with a key role in pharmacological effects.…”
Section: Introductionmentioning
confidence: 99%
“…[20][21][22] High ABCB1 expression is usually associated with poor prognosis in cancer patients. 23,24 It affects the absorption, distribution, metabolism, and excretion of drugs [25][26][27] such as the anticancer medicines colchicine, quinidine, tacrolimus, etoposide, doxorubicin, paclitaxel, and vinblastine. 26 The overexpression of ABCB1 in cancer cells increases drug efflux and reduces drug concentrations, thus reducing the cytotoxicity of the drug against tumor cells and resulting in drug resistance.…”
Section: Discussionmentioning
confidence: 99%
“…Drug metabolism enzymes are critical factors for drug bioavailability. The cytochrome P450 enzyme (CYP450) is one of the crucial hepatic enzymes, responsible for most of the drug metabolism [134]. CYP2D6 is one of the major subtypes of cytochrome P450 [135].…”
Section: Pharmacokinetics and Toxicological Propertiesmentioning
confidence: 99%